RESUMO
Proteomic analyses are rapid and powerful tools that are used to increase the understanding of cancer pathogenesis, discover cancer biomarkers and predictive markers, and select and monitor novel targets for cancer therapy. Feline injection-site sarcomas (FISS) are aggressive skin tumours with high recurrence rates, despite treatment with surgery, radiotherapy, and chemotherapy. Doxorubicin is a drug of choice for soft tissue sarcomas, including FISS. However, multidrug resistance is one of the major causes of chemotherapy failure. The main aim of the present study was to identify proteins that differentiate doxorubicin-resistant from doxorubicin-sensitive FISS using two-dimensional gel electrophoresis (2DE), followed by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) analysis. Using the three-dimensional (3D) preclinical in ovo model, which resembles features of spontaneous fibrosarcomas, three significantly (p ≤ 0.05) differentially expressed proteins were identified in tumours grown from doxorubicin-resistant fibrosarcoma cell lines (FFS1 and FFS3) in comparison to the doxorubicin-sensitive one (FFS5): Annexin A5 (ANXA5), Annexin A3 (ANXA3), and meiosis-specific nuclear structural protein 1 (MNS1). Moreover, nine other proteins were significantly differentially expressed in tumours grown from the high doxorubicin-resistant cell line (FFS1) in comparison to sensitive one (FFS5). This study may be the first proteomic fingerprinting of FISS reported, identifying potential candidates for specific predictive biomarkers and research targets for doxorubicin-resistant FISS.
Assuntos
Resistencia a Medicamentos Antineoplásicos , Fibrossarcoma/metabolismo , Proteoma/genética , Infecções por Retroviridae/metabolismo , Infecções Tumorais por Vírus/metabolismo , Animais , Antineoplásicos/farmacologia , Gatos , Linhagem Celular Tumoral , Embrião de Galinha , Doxorrubicina/farmacologia , Fibrossarcoma/genética , Proteoma/metabolismo , Infecções por Retroviridae/genética , Vírus do Sarcoma Felino , Infecções Tumorais por Vírus/genéticaRESUMO
The cFMS (cellular homolog of the V-FMS oncogene product of the Susan McDonough strain of feline sarcoma virus) (Proc Natl Acad Sci U S A 83:3331-3335, 1986) kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) inhibits colony-stimulating factor (CSF)-1-induced monocyte growth and bone degradation in vitro and inhibits CSF-1 signaling through cFMS kinase in 4-day models in mice (Proc Natl Acad Sci U S A 102:16078, 2005). In the present study, the kinase selectivity of GW2580 was further characterized, and the effects of chronic treatment were evaluated in normal and arthritic rats. GW2580 selectively inhibited cFMS kinase compared with 186 other kinases in vitro and completely inhibited CSF-1-induced growth of rat monocytes, with an IC(50) value of 0.2 microM. GW2580 dosed orally at 25 and 75 mg/kg 1 and 5 h before the injection of lipopolysaccharide inhibited tumor necrosis factor-alpha production by 60 to 85%, indicating a duration of action of at least 5 h. In a 21-day adjuvant arthritis model, GW2580 dosed twice a day (b.i.d.) from days 0 to 21, 7 to 21, or 14 to 21 inhibited joint connective tissue and bone destruction as assessed by radiology, histology and bone mineral content measurements. In contrast, GW2580 did not affect ankle swelling in the adjuvant model nor did it affect ankle swelling in a model where local arthritis is reactivated by peptidoglycan polysaccharide polymers. GW2580 administered to normal rats for 21 days showed no effects on tissue histology and only modest changes in serum clinical chemistry and blood hematology. In conclusion, GW2580 was effective in preserving joint integrity in the adjuvant arthritis model while showing minimal effects in normal rats.
Assuntos
Anisóis/uso terapêutico , Artrite Experimental/tratamento farmacológico , Artrite Experimental/enzimologia , Inibidores de Proteínas Quinases/uso terapêutico , Pirimidinas/uso terapêutico , Receptor de Fator Estimulador de Colônias de Macrófagos/antagonistas & inibidores , Animais , Anisóis/farmacologia , Artrite Experimental/patologia , Células Cultivadas , Humanos , Masculino , Inibidores de Proteínas Quinases/farmacologia , Pirimidinas/farmacologia , Ratos , Ratos Endogâmicos Lew , Vírus do Sarcoma Felino/efeitos dos fármacos , Vírus do Sarcoma Felino/enzimologiaRESUMO
Diffuse iris melanoma was confirmed by light-microscopic examination in 10 formalin-fixed, paraffin-embedded globes from 10 cats. To determine if feline leukemia virus or a replication defective feline leukemia virus, feline sarcoma virus, was present in these anterior uveal melanomas, immunohistochemistry and polymerase chain reaction for feline leukemia virus were utilized. Immunohistochemical staining for feline leukemia virus glycoprotein 70 was performed on all 10 tumors using an avidin-biotin complex technique. The DNA was extracted from each specimen and a 166-base pair region of the feline leukemia virus long terminal repeat was targeted by polymerase chain reaction. Immunohistochemical staining for feline leukemia virus glycoprotein 70 and polymerase chain reaction amplification of a feline leukemia virus long terminal repeat region were negative in all cases. Feline leukemia virus/feline sarcoma virus was not detected in any neoplasms and therefore was unlikely to play a role in the tumorigenesis of these feline diffuse iris melanomas.
Assuntos
Doenças do Gato/patologia , Neoplasias da Íris/veterinária , Melanoma/veterinária , Animais , Doenças do Gato/virologia , Gatos , Imuno-Histoquímica , Neoplasias da Íris/patologia , Vírus da Leucemia Felina/patogenicidade , Melanoma/patologia , Reação em Cadeia da Polimerase/veterinária , Vírus do Sarcoma Felino/patogenicidadeRESUMO
The v-fgr oncogene encodes a chimeric oncoprotein composed of feline sarcoma virus (FeSV)-derived gag and cellular-derived actin and c-Fgr sequences. v-Fgr is myristoylated and membrane bound, two criteria which must be met for src kinases to induce cellular transformation. Although inhibition of myristoylation resulted in a decreased ability of v-Fgr to sediment with membranes from an NIH-3T3 P100 fraction, deletion of the gag domain caused nearly all of the protein to remain unbound and cytosolic. Systematic deletions within gag indicate that while amino acids 3 through 9 are critical determinants of myristoylation and/or define a domain which directs membrane localization, these residues cooperate with additional gag sequences when anchoring the protein to the plasma membrane. Furthermore, nonmyristoylated and/or cytoplasmic variants of v-Fgr failed to induce anchorage-independent growth of NIH-3T3 cells, indicating that proper subcellular localization of v-Fgr is a key factor in its ability to induce transformation.
Assuntos
Transformação Celular Viral , Produtos do Gene gag/genética , Produtos do Gene gag/metabolismo , Proteínas Oncogênicas de Retroviridae/genética , Proteínas Oncogênicas de Retroviridae/metabolismo , Células 3T3 , Animais , Sítios de Ligação/genética , Gatos , Transformação Celular Viral/genética , Camundongos , Mutação , Ligação Proteica , Proteínas Tirosina Quinases/genética , Proteínas Tirosina Quinases/metabolismo , Vírus do Sarcoma Felino/genéticaRESUMO
BACKGROUND: Snyder-Theilen feline sarcoma virus (ST:FeSV)-transduced human fibroblasts differentiate into tissue macrophages(1-9). The ST:FeSV-induced macrophages demonstrate macrophage-mediated cytotoxicity (MTC) and antibody-dependent cellular cytotoxicity (ADCC), including growth modulation of tumor cells in agar (3,4,6). MATERIALS AND METHODS: Here we tested the effects of ST:FeSV-induced macrophages in agar on the following human tumor cell lines: colon adenocarcinoma, prostate adenocarcinoma, breast adenocarcinoma, malignant melanoma, leiomyosarcoma, fibrosarcoma, and fibrous histiocytoma. The tumor cells were co-incubated in agar with ST:FeSV-induced macrophages in the absence or presence of 10% fetal bovine serum (FBS). RESULTS: Regardless of serum conditions, the growth of all tumor cells tested was inhibited considerably by the ST:FeSV-induced macrophages. Colon adenocarcinoma cells were the least affected, and fibrosarcoma or fibrous histiocytoma cells were the most sensitive to growth inhibition by the ST:FeSV-induced macrophages. A notable exception was the growth stimulation of breast adenocarcinoma (BT-20; MCF-7), and of prostate adenocarcinoma (TSU-prl) tumor cell lines by the ST:FeSV-induced macrophages in the absence of FBS. CONCLUSIONS: The results attest to the potency of secreted proteins that are expressed by ST:FeSVinduced macrophages which can modulate tumor cell growth in agar. The results further indicate that serum is likely to have an impact on the effects of these growth regulatory factors on human tumor cells.
Assuntos
Fibroblastos/citologia , Macrófagos/imunologia , Vírus do Sarcoma Felino , Células Tumorais Cultivadas/citologia , Sangue , Diferenciação Celular , Divisão Celular , Meios de Cultura , Humanos , Macrófagos/citologia , Macrófagos/virologia , Óxido Nítrico/fisiologia , Transdução Genética , Células Tumorais Cultivadas/imunologiaRESUMO
Inbred adult female rats were immunized against syngeneic ST-FeSV induced sarcoma cells. ST-FeSV was injected subcutaneously into 57 neonates (vaccinated) born from these immunized females and into 60 non-vaccinated syngeneic neonates. Serum thymic factor (FTS) was injected subcutaneously into 10 of vaccinated and 30 of non-vaccinated rats. Sarcomas developed in 40.4% (19/47) of vaccinated (A), 20.0% (2/10) of vaccinated FTS injected (B), 63.3% (19/30) of non-vaccinated FTS injected (C), and 76.7% (23/30) of non-treated (D) rats. By AB immunostaining using antibody to v-fes product (P85), sarcomas developed in 10 of 13 rats of group C tested, and 3 of 6 rats of group D tested were positive, but those in 7 rats of group A and 2 rats of group B tested were all negative. Lung metastasis was observed in rats of all groups except those of B group. All sera of animals that developed sarcomas were positive to P85 in Western blot analysis. These results showed that FTS augmented suppressive effects on sarcoma development in hosts immune to the viral oncogene product.
Assuntos
Vacinas Anticâncer , Proteínas Oncogênicas/imunologia , Vírus do Sarcoma Felino/imunologia , Sarcoma Experimental/imunologia , Sarcoma Experimental/prevenção & controle , Fator Tímico Circulante/farmacologia , Animais , Animais Recém-Nascidos , Gatos , Feminino , Ratos , Ratos Wistar , Sarcoma Experimental/patologiaRESUMO
OBJECTIVE: To determine whether there was intralesional infection or expression of FeLV or feline sarcoma virus in suspected vaccine-associated fibrosarcomas in cats. DESIGN: Prospective case series. SAMPLE POPULATION: 130 suspected vaccine-associated fibrosarcomas from cats and 1 multicentric fibrosarcoma from 1 cat. PROCEDURE: Excisional biopsy specimens were fixed in formalin and embedded in paraffin. Expression of FeLV antigen was assessed, using a polyclonal goat anti-FeLV glycoprotein 70 (gp 70) serum and an avidinbiotin immunoperoxidase staining technique. The FeLV genome was detected with a polymerase chain reaction (PCR), using primers targeted to a conserved sequence in the untranslated region of the long terminal repeat (LTR) of the FeLV. RESULTS: FeLV gp 70 and LTR sequence were detected in a multicentric fibrosarcoma. All 130 of the suspected vaccine-associated fibrosarcomas were FeLV gp 70 negative on the basis of immunohistochemical test results: 100 fibrosarcomas also were examined by use of PCR and were negative for FeLV LTR region. CLINICAL IMPLICATIONS: Exogenous retroviruses, FeLV, and feline sarcoma virus were not detected in these suspected vaccine-associated fibrosarcomas, using immunohistochemistry and PCR. Additional testing will be required to determine the nature of genomic alterations that are involved in the oncogenesis of vaccine-associated fibrosarcomas in cats.
Assuntos
Doenças do Gato/virologia , Fibrossarcoma/veterinária , Vírus da Leucemia Felina/isolamento & purificação , Vírus do Sarcoma Felino/isolamento & purificação , Animais , Biópsia/veterinária , Doenças do Gato/etiologia , Gatos , Sequência Conservada , DNA Viral/análise , Fibrossarcoma/etiologia , Fibrossarcoma/virologia , Formaldeído , Imuno-Histoquímica , Injeções/efeitos adversos , Injeções/veterinária , Vírus da Leucemia Felina/genética , Vírus da Leucemia Felina/imunologia , Inclusão em Parafina , Reação em Cadeia da Polimerase/veterinária , Estudos Prospectivos , Sequências Repetitivas de Ácido Nucleico , Proteínas Oncogênicas de Retroviridae/análise , Proteínas Oncogênicas de Retroviridae/imunologia , Vírus do Sarcoma Felino/genética , Vírus do Sarcoma Felino/imunologia , Fixação de Tecidos , Vacinas/efeitos adversos , Proteínas do Envelope Viral/análise , Proteínas do Envelope Viral/imunologiaRESUMO
Expression of the v-fms oncogene of feline sarcoma virus in fibroblasts causes surface exposure of an activated receptor tyrosine kinase, v-Fms, that is autophosphorylated at multiple sites within its cytoplasmic domain. Cellular proteins interacting with this part of v-Fms modulate the mitogenic activity and morphology of the cells. We show here that the tyrosine residue in position 807 (Y-807) of the v-Fms molecule constitutes a major autophosphorylation site. The replacement of this residue by phenylalanine (Y807F mutation) allowed us to functionally dissect v-Fms-specific mitogenic and morphogenic cascades. Cells expressing the mutant v-Fms molecule resembled wild-type (wt) v-Fms-transformed (wt-v-Fms) cells in terms of [3H]thymidine uptake rates and activation of the Ras/Raf-1 mitogenic cascade. Such cells showed, however, a flat morphology and contained intact actin cables and fibronectin network. Our studies indicate that the v-Fms molecule controls cell morphology by a cascade that involves a direct interaction with p120RasGAP and p190RhoGAP: (i) in contrast to wt v-Fms molecules, the Y807F v-Fms protein failed to associate with and phosphorylate p120RasGAP; (ii) tight complexes between p120RasGAP and p190RhoGAP as well as detectable RhoGAP activity were present exclusively in wt-v-Fms cells; and (iii) p190RhoGAP was dispersed throughout the cytoplasm of wt-v-Fms cells, whereas its distribution was restricted to perinuclear regions of cells expressing the mutant v-Fms gene.
Assuntos
Transformação Celular Neoplásica , Genes fms , Proteína Oncogênica gp140(v-fms)/metabolismo , Oncogenes , Proteínas Tirosina Quinases/metabolismo , Proteínas/metabolismo , Vírus do Sarcoma Felino/fisiologia , Tirosina , Células 3T3 , Sequência de Aminoácidos , Animais , Replicação do DNA , Proteínas Ativadoras de GTPase , Glutationa Transferase/biossíntese , Cinética , Camundongos , Proteína Oncogênica gp140(v-fms)/biossíntese , Proteína Oncogênica gp140(v-fms)/isolamento & purificação , Fenilalanina , Plasmídeos , Mutação Puntual , Proteínas/isolamento & purificação , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/isolamento & purificação , Proteínas Recombinantes de Fusão/metabolismo , Vírus do Sarcoma Felino/genética , Timidina/metabolismo , Transfecção , Proteínas Ativadoras de ras GTPaseRESUMO
In sarcomagenesis in rats infected neonatally with feline sarcoma virus (ST-FeSV), v-fes product (P85) was previously shown by us to be a predictive and preventive determinant. In order to explore the part played by P85 in tumor suppression, DNA was extracted from precancerous granulomas and from slow or rapid growing sarcomas induced by neonatal injection of the virus. The v-fes signal from extracted DNA was analyzed by PCR-SSCP. The prototype v-fes gene signal was detected in most lesions and found to be generally amplified in rapid growing sarcomas and in some granulomas. Several v-fes homologs showing varying mobilities in gel were seen in most sarcomas and some granulomas with or without the prototype v-fes signal. In slow growing sarcomas and granulomas induced in hosts that were immunized with ST-FeSV induced syngeneic sarcoma and proved to carry IgG antibody to P85, the prototype v-fes gene was found to be down-regulated and v-fes homologs were found to be reduced in number or eliminated. These results suggest that the development of v-fes mutations is associated with the growth potential of cells carrying the v-fes gene, and that host immunity to v-onc product influences the development of virogene rearrangements and results in slow and suppressed growth of tumors caused by neonatal infection with retrovirus.
Assuntos
Proteínas de Fusão gag-onc/biossíntese , Oncogenes , Vírus do Sarcoma Felino/patogenicidade , Sarcoma Experimental/genética , Sarcoma Experimental/patologia , Vacinas Virais , Animais , Animais Recém-Nascidos , Sequência de Bases , Gatos , Linhagem Celular , Primers do DNA , DNA Viral/análise , Feminino , Proteínas de Fusão gag-onc/genética , Granuloma/patologia , Granuloma/virologia , Hibridização In Situ , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Sinais Direcionadores de Proteínas/biossíntese , Ratos , Ratos Wistar , Vírus do Sarcoma Felino/genética , Vírus do Sarcoma Felino/isolamento & purificação , Sarcoma Experimental/prevenção & controle , Sarcoma Experimental/virologiaRESUMO
Cell transformation is characterized by overt changes in growth control and cell morphology. To study the role of tyrosine residues Y705 and Y807 of v-Fms of the McDonough strain of feline sarcoma virus in cell transformation we replaced them individually with phenylalanine residues. Cells expressing the mutant genes showed mitogenic properties similar to wild-type v-Fms transformed cells. However, the morphology of cells expressing the Y807F mutant remained the same as nontransformed cells. Four phosphoproteins of 190, 120, 55 and 50 kDa were detected in cells expressing the wild-type but were absent in cells expressing the mutant Y807F-v-fms gene.
Assuntos
Transformação Celular Viral , Proteína Oncogênica gp140(v-fms)/fisiologia , Vírus do Sarcoma Felino/fisiologia , Tirosina/fisiologia , Sequência de Bases , Linhagem Celular Transformada , Dados de Sequência Molecular , Oligodesoxirribonucleotídeos , Proteína Oncogênica gp140(v-fms)/química , Fosforilação , Vírus do Sarcoma Felino/químicaRESUMO
The decisive role of macrophages in T-cell differentiation is best exemplified by cutaneous leishmaniasis. During infection, Leishmania attach to macrophages, the only site of replication for the parasite. We have recently demonstrated the conversion of human fibroblasts to tissue macrophages (TM) by transduction with the Snyder-Theilen feline sarcoma virus (ST:FeSV-(FeLV)). Since Leishmania have tropism only for macrophages, we have used the parasite to ascertain the functional phenotype of the ST:FeSV-induced TM. Here, we have demonstrated the productive infection of the ST:FeSV-induced TM by L. major. These results point to the utility of ST:FeSV-induced TM in studies that concern the role of human macrophages in T-cell differentiation during the course of infection by Leishmania.
Assuntos
Transformação Celular Viral , Fibroblastos/citologia , Leishmania major/fisiologia , Macrófagos/citologia , Macrófagos/parasitologia , Vírus do Sarcoma Felino/fisiologia , Animais , Diferenciação Celular , Células Cultivadas , Fibroblastos/virologia , Humanos , Vírus da Leucemia Felina/fisiologia , Macrófagos/ultraestrutura , Monócitos/parasitologia , Transdução de SinaisRESUMO
Feline sarcoma virus of Snyder-Theilen strain (ST-FeSV) induces sarcomas in Wistar/Ma rats following neonatal virus injection. Induced tumors express the viral oncogene product (P85) and elicit in hosts the specific serum anti-P85 antibody detectable by Western blot analysis. Syngeneic adult female rats were immunized with an ST-FeSV induced sarcoma that was 100% transplantable to syngeneic adult rats. Newborns from immunized rats (vaccinated rats) were found to carry anti-P85 in their sera at birth. Following neonatal injection of the virus to vaccinated and non-vaccinated control rats, tumor incidence was found to be lower and survival time significantly longer in vaccinated rats than in controls (p < 0.01). A nonapeptide known to be thymic hormone (FTS) showed suppressive effects on tumor development. These results indicate that tumors caused by perinatal retrovirus infection may be suppressed by efficient elicitation of cell-mediated immune response against the product of oncogene of the causative virus.
Assuntos
Proteínas Oncogênicas Virais/imunologia , Infecções por Retroviridae/prevenção & controle , Vírus do Sarcoma Felino/imunologia , Sarcoma Experimental/prevenção & controle , Infecções Tumorais por Vírus/prevenção & controle , Sequência de Aminoácidos , Animais , Anticorpos Antivirais/sangue , Feminino , Imunidade Celular , Imunidade Materno-Adquirida , Dados de Sequência Molecular , Ratos , Ratos Wistar , VacinaçãoRESUMO
Activation of the c-abl protooncogene occurs in Abelson murine leukemia virus, Hardy-Zuckerman-2 feline sarcoma virus, and during the chromosomal translocation that generates the BCRABL fusion gene. The three genes exhibit varying degrees of transforming activity; the two viral genes transform NIH-3T3 cells in vitro, whereas the BCRABL gene is incapable of transforming these cells. To determine whether genetic alterations can enhance the transforming potential of the BCRABL gene, we employed genetic selection techniques which led to the isolation of a mutant form of the BCRABL gene with high levels of fibroblastic transforming activity. Molecular analysis of this clone shows that it suffered a deletion of 3' ABL sequences and their replacement with a cellular sequence of unknown origin, termed X. This tripartite gene is capable of inducing 35 foci/10 ng of DNA. Deletion of 3' ABL sequences analogous to that seen in the activated BCRABL protein without the addition of X yields 5 foci/100 ng of DNA. These results suggest that carboxyl-terminal truncations unmask the fibroblastic transforming activity of the BCRABL gene product and the addition of X sequences dramatically enhances this transforming potential, indicating a dominant contribution by the X reading frame.
Assuntos
Transformação Celular Neoplásica , Proteínas de Fusão bcr-abl/metabolismo , Células 3T3 , Vírus da Leucemia Murina de Abelson/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Linhagem Celular Transformada , Clonagem Molecular , Proteínas de Fusão bcr-abl/biossíntese , Proteínas de Fusão bcr-abl/genética , Regulação Viral da Expressão Gênica , Genes abl , Biblioteca Genômica , Camundongos , Dados de Sequência Molecular , Mapeamento por Restrição , Vírus do Sarcoma Felino/genética , Deleção de Sequência , Translocação GenéticaRESUMO
We investigated the transforming domain of a recently isolated feline sarcoma virus (TP1-FeSV) which encodes a fgr-related tyrosine kinase expressed as a gag-fgr fusion protein. The gag portion was removed and replication-competent expression vectors (RCAS) with inserted v-fgr sequences were established. Chicken embryo fibroblasts (CEF) were transfected and monitored for replication, integration and transcription of the proviral constructs. We demonstrated that transfected cells display morphological changes and are able to form colonies in soft-agar. This suggests that the gag portion of the fusion protein from TP1-FeSV is not necessary for the transformation of fibroblasts.
Assuntos
Transformação Celular Viral , Proteínas Tirosina Quinases/genética , Proteínas Oncogênicas de Retroviridae/genética , Vírus do Sarcoma Felino/genética , Animais , Sítios de Ligação , Células Cultivadas , Embrião de Galinha , Clonagem Molecular , DNA Viral/análise , Fibroblastos , Genes Virais , Genes gag , Proteínas Tirosina Quinases/química , Proteínas Tirosina Quinases/fisiologia , RNA Viral/análise , Proteínas Oncogênicas de Retroviridae/química , Proteínas Oncogênicas de Retroviridae/fisiologia , Vírus do Sarcoma Felino/enzimologia , Vírus do Sarcoma Felino/fisiologia , TransfecçãoRESUMO
The feline sarcoma virus oncogene v-fms has significantly contributed to the dissection of peptide growth factor action since it encodes the transmembrane tyrosine kinase gp140v-fms, a transforming version of colony-stimulating factor 1 receptor, a member of the growth factor receptor tyrosine kinase family. In this study, the functional significance of structural differences between distinct tyrosine kinase types, in particular between cellular receptors and viral transforming proteins of distinct structural types, has been further investigated, and their functional compatibility has been addressed. For this purpose, major functional domains of three structurally distinct tyrosine kinases were combined into two chimeric receptors. The cytoplasmic gp140v-fms kinase domain and the kinase domain of Rous sarcoma virus pp60v-src were each fused to the extracellular ligand-binding domain of the epidermal growth factor (EGF) receptor to create chimeras EFR and ESR, respectively, which were studied upon stable expression in NIH 3T3 fibroblasts. Both chimeras were faithfully synthesized and routed to the cell surface, where they displayed EGF-specific, low-affinity ligand-binding domains in contrast to the high- and low-affinity EGF-binding sites of normal EGF receptors. While the EFR kinase was EGF controlled for autophosphorylation and substrate phosphorylation in vitro, in vivo, and in digitonin-treated cells, the ESR kinase was not responsive to EGF. While ESR appeared to recycle to the cell surface upon endocytosis, EGF induced efficient EFR internalization and degradation, and phorbol esters stimulated protein kinase C-mediated downmodulation of EFR. Despite its ligand-inducible kinase activity, EFR was partly EGF independent in mediating mitogenesis and cell transformation, while ESR appeared biologically inactive.
Assuntos
Fator de Crescimento Epidérmico/farmacologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Regulação Viral da Expressão Gênica/efeitos dos fármacos , Proteína Oncogênica gp140(v-fms)/metabolismo , Proteínas Tirosina Quinases/metabolismo , Vírus do Sarcoma Felino/enzimologia , Células 3T3 , Animais , Sequência de Bases , Transporte Biológico , Adesão Celular , Divisão Celular/efeitos dos fármacos , Transformação Celular Neoplásica , Regulação para Baixo , Ativação Enzimática , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/metabolismo , Substâncias de Crescimento/farmacologia , Camundongos , Dados de Sequência Molecular , Proteína Oncogênica gp140(v-fms)/genética , Proteína Oncogênica pp60(v-src)/genética , Proteína Oncogênica pp60(v-src)/metabolismo , Proteínas Tirosina Quinases/genética , Proteínas Recombinantes de Fusão/metabolismo , TransfecçãoRESUMO
We have previously demonstrated the conversion of human fibroblasts (HF) to tissue macrophages by transduction with the Snyder-Theilen feline sarcoma virus (ST:FeSV) [1-3]. The ST:FeSV-induced TM have been characterized both phenotypically and functionally, including their tumouricidal potential against colon adenocarcinoma (LS 180) cells. The present results show that ST:FeSV-induced TM produced significant lysis of K-562 tumour cells, but essentially no lysis of the Daudi tumour cells. Lysis of K-562 tumour cells by the ST:FeSV-induced TM was considerably more effective in 1% than in 10% FCS. Addition of TNF-alpha caused only a slight increase in the extent of lysis of K-562 tumour cells by the ST:FeSV-induced TM. Coincubation of the ST:FeSV-induced TM with K-562 cells in agar medium resulted in the inhibition of tumour cell proliferation. The results indicate that ST:FeSV-induced TM are potent oncocytotoxic agents of K-562 tumour cells, but are considerably less effective against the Daudi tumour cells.
Assuntos
Linfoma de Burkitt/patologia , Fibroblastos/citologia , Leucemia Eritroblástica Aguda/patologia , Macrófagos/fisiologia , Vírus do Sarcoma Felino/fisiologia , Sequência de Aminoácidos , Fenômenos Fisiológicos Sanguíneos , Diferenciação Celular/efeitos dos fármacos , Fatores Quimiotáticos/farmacologia , Meios de Cultura/farmacologia , Citotoxicidade Imunológica , Elastina/farmacologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/microbiologia , Proteínas de Fusão gag-onc/fisiologia , Humanos , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Fator Estimulador de Colônias de Macrófagos/farmacologia , Macrófagos/citologia , Macrófagos/microbiologia , Dados de Sequência Molecular , N-Formilmetionina Leucil-Fenilalanina/farmacologia , Fragmentos de Peptídeos/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Transdução Genética , Células Tumorais CultivadasRESUMO
In earlier studies [1-3], we have demonstrated the conversion of human fibroblasts (HF) to tissue macrophages (TM) by the Snyder-Theilen feline sarcoma virus (ST:(FeSV)). The purpose of the present study is to determine the cytolytic potential of ST:FeSV(FeLV)-induced TM against tumorigenic target cells under defined conditions in vitro. The results show that ST:FeSV-induced TM, but not mock-infected HF, produced significant lysis of human colon adenocarcinoma cells (LS-180) after a 3-day preincubation period, followed by a 4-day coincubation period at an effector to target cell ratio of 5:1. The presence of IFN-gamma, or lipopolysaccharides (LPS), and especially of M-CSF, during the coincubation period generally yielded optimal lysis of the tumor cells. Addition of LS-180 specific antibody (NRCO-4) substantially increased the cytolytic potential of TM. Significantly, coincubation of TM with LS-180 tumor cells in an agar medium, where no direct contact between cells occurs, resulted in the inhibition of tumor cell proliferation. Addition of LPS has further accentuated this inhibition. The results indicate that ST:FeSV-induced macrophages are potent oncocytolytic agents of LS-180 tumor cells in the absence and in the presence of direct contact between effector and target cells.
Assuntos
Adenocarcinoma/imunologia , Transformação Celular Viral , Neoplasias do Colo/imunologia , Citotoxicidade Imunológica , Fibroblastos/citologia , Macrófagos/citologia , Vírus do Sarcoma Felino/fisiologia , Humanos , Macrófagos/imunologia , Células Tumorais CultivadasRESUMO
In an earlier study, we have demonstrated the conversion of human fibroblasts (HF) to tissue macrophages (TM) by the Snyder-Theilen feline sarcoma virus (ST:(FeSV)) [1]. The present study shows that conversion of cultured HF by the ST:FeSV to TM resulted in the de-novo expression of interleukin-1 alpha, IL-1 beta, interferon-alpha, tumor necrosis factor-alpha, granulocyte-macrophage colony stimulating factor, and CD4. The conversion of HF to TM was also associated with increased expression of non-specific esterases as well as increased amount of ingested lipid material by the TM. Clonotypic and organotypic analyses of cells infected with the ST:FeSV(FeLV) showed a similar degree of conversion to TM among eleven individual clones of skin fibroblasts, and among fibroblasts obtained from eight different organs. These findings bear on the origin (heterogeneity) of TM, the nature of TM-induced cytokines, and the potential role of ST:FeSV-recruited TM during immune reactions in vivo.